Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our growing Research & Development team in Heidelberg, Germany, we are looking for a
(Reference No. OP2002)
The successful candidate will be an integral member an international program team tasked with developing new antibody drug candidates from non-clinical research to clinical trials.
Professional qualifications, expertise and skills
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary and collegial team.
For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail: email@example.com).